BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16398061)

  • 1. Closing remarks: current position of calcium channel antagonists in hypertension--the role of manidipine.
    Zanchetti A
    Drugs; 2005; 65 Suppl 2():40-2. PubMed ID: 16398061
    [No Abstract]   [Full Text] [Related]  

  • 2. Delapril/manidipine: viewpoints.
    Kahan T; Ambrosioni E
    Drugs; 2006; 66(7):970-1. PubMed ID: 16740019
    [No Abstract]   [Full Text] [Related]  

  • 3. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of manidipine.
    Roca-Cusachs A; Triposkiadis F
    Drugs; 2005; 65 Suppl 2():11-9. PubMed ID: 16398058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine].
    Martínez Martín FJ
    Nefrologia; 2007; 27 Suppl 6():26-35. PubMed ID: 18225601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern calcium channel blockade. Lowering blood pressure with added benefits].
    MMW Fortschr Med; 2001 Feb; 143(6):57. PubMed ID: 11247372
    [No Abstract]   [Full Text] [Related]  

  • 9. The SYST-EUR study and beyond: immediate versus delayed treatment of isolated systolic hypertension.
    van Zwieten PA;
    J Hypertens; 2004 Apr; 22(4):689-90. PubMed ID: 15126908
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of manidipine on circadian blood pressure in essential hypertension.
    Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
    Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
    Staessen JA; Birkenhäger WH; Fagard RH
    Eur Heart J; 2000 Jan; 21(1):2-7. PubMed ID: 10610733
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium channel blocker.
    Li CJ; Shi ZD
    Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
    [No Abstract]   [Full Text] [Related]  

  • 13. Delapril/manidipine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(7):961-9. PubMed ID: 16740017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders.
    Mizuno K; Haga H; Takahashi M; Watanabe Y; Fukuchi S
    Blood Press Suppl; 1992; 3():119-23. PubMed ID: 1343279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
    MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative hypotensive effectiveness of various calcium antagonists in patients with persistent essential hypertension (randomized study)].
    Akhadov ShV; Belousov IuB; Borisova EO; Volkov MG
    Kardiologiia; 1992; 32(11-12):13-5. PubMed ID: 1297870
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intima-media thickness in hypertensive patients. Calcium blockers controls atherosclerosis].
    MMW Fortschr Med; 2002 Jan; 144(1-2):66-7. PubMed ID: 11847890
    [No Abstract]   [Full Text] [Related]  

  • 18. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ; Saiz-Satjes M
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
    Fogari R; Corradi L; Zoppi A; Lazzari P; Mugellini A; Preti P; Rinaldi A
    Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.